معرفی
A. David Paltiel is a Professor of Public Health (Health Policy) at Yale School of Public Health, with secondary appointments in the Institution for Social and Policy Studies and the School of Management. His work bridges the fields of health policy, operations research, and public health modeling, focusing on evidence-based decision-making for resource allocation in healthcare.
Dr. Paltiel earned his PhD in Operations Research from Yale University in 1992, following an MBA from Yale (1985) and a BA from McGill University (1981). This unique combination of business, mathematical, and public health training has shaped his approach to health services research and policy analysis.
His research focuses on the application of mathematical modeling and cost-effectiveness analysis to critical public health problems, particularly HIV/AIDS prevention and treatment. Dr. Paltiel has developed sophisticated simulation models to evaluate the clinical and economic implications of various health interventions. His work spans both domestic and international settings, with significant contributions to understanding optimal HIV prevention strategies in South Africa and the United States. He has also expanded his modeling expertise to address other public health challenges including tobacco control, osteoarthritis management, and infectious disease surveillance for diseases like tuberculosis and COVID-19.
Dr. Paltiel's publication record demonstrates a consistent trajectory of high-impact research in public health modeling. His recent work (2023-2025) shows increasing sophistication in modeling approaches, with applications ranging from HIV prevention resource allocation to optimizing vaccination strategies during the pandemic. A notable trend is the integration of machine learning techniques with traditional modeling approaches, as seen in his work on bandit algorithms for infectious disease surveillance.
- Connecticut Academy of Science and Engineering (2014)
Dr. Paltiel has secured substantial research funding from NIH, CDC, and the Bill & Melinda Gates Foundation to support his work on HIV modeling, cost-effectiveness analysis, and public health policy. His major projects include the NIMH-funded research on novel approaches to HIV prevention, CDC-funded collaborative work on economic modeling for HIV and other infectious diseases, and NIAID-funded work on the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) model. He serves as a key collaborator on multiple international research initiatives, particularly those focused on optimizing HIV care in resource-limited settings.
